Our website is set to 'allow cookies' to give you the best experience without telling us who you are. Please continue if you consent to this, or click below to change your settings:
Find out more about our cookies policy
(+1) 617 896 0213
info@sagentia.com
View all hot topics
1/4
There are many implications from the European Parliament’s new proposals for both Medical Devices Regulation and IVD Devices Regulation that will be critical for medical device manufacturers operating in the eurozone.
Recent research published in The Lancet suggests that the bird flu strain H7N9 is becoming resistant to current drug therapies.
Personalisation is undeniably a current and growing trend in personal care but we are yet to see whether this kind of ‘in situ’ measurement approach will really take off.
It was announced Monday morning that Life Technologies has been purchased by Thermo Fisher for $13.6bn. Whist this acquisition is not totally unexpected, it is Life Tech’s DNA sequencing technology - Ion Torrent - that is of particular interest in this case.
Last week the European Organization for Nuclear Research, or CERN, announced that their research endeavours ‘strongly indicate’ that they have solid evidence of the Higgs Boson particle. What is the value of this discovery beyond academic research?
Management Forum’s Injectable Drug Delivery conference in London last week highlighted the importance of parenteral drug delivery both now and in the future.
The horse meat scandal has caused a media storm, and provided more than a few jokes around the topic, but apart from the mislabelling of goods and misleading the public about what they were eating, is there any danger? And how can a similar scandal be prevented in the future?
Which skin cream do I buy? How often should I apply it? These and other personal care questions are increasingly being answered on what seems like a personalised one-to-one basis. But how could this be possible when a skin or haircare product is bought by 10’s of millions of consumers every year?
The Medical Device R&D Summit brings together medical device R&D executives with leading solution providers. The summit offers an intimate environment for focused discussion on cutting-edge technology, strategy and implementation of solutions, helping companies to stay ahead in the market.
The American Association for Clinical Chemistry holds its Annual Meeting and Clinical Lab Expo this year in Houston from 28 July - 1 August 2013. The congress offers the opportunity to learn about new developments in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.
Sagentia teams up with other industry experts to present a must-attend session at HBA Global Expo where key dynamics and trends of the growing do-it-yourself (DIY) beauty consumer will be explored.
Sagentia is offering 10 bursaries of £2,500 to support science and engineering students during the academic year starting September 2013. Sagentia’s STEM Bursary Scheme is a new initiative from the company which aims to support the development of science and engineering skills in the UK.
In an article published in HAPPI magazine Dr. Peter Luebcke, Senior Personal Care Consultant at Sagentia, explores the challenges faced by cosmetic companies when constantly pushing the boundaries of the cosmetic definition to claim one-upmanship efficacy of their products.
As IVD devices move into the hands of untrained consumers, user-centered design is critical. Sagentia explores how usability is key to understanding these new environments, published in MDDI.
Experts in complex science & technology Multidisciplinary, cross sector team approach Excel at meeting aggressive timescales Customer friendly approach to IP Accreditation to ISO9001:2008 and ISO13485:2003 What our clients say: "We have worked with Sagentia on a number of issues. The reason in every case is their ability to deliver innovative engineering and then deliver on execution."
Keep track of site upates using our RSS feeds, click a link below to view the feed.